TSPO-PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia.
8 affiliations
- 1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
- 2UK Dementia Research Institute, University of Cambridge, Cambridge, UK.
- 3Cambridge University Hospitals NHS Trust, Cambridge, UK.
- 4Department of Imaging and Pathology, University of Leuven, Louvain, Belgium.
- 5Department of Psychiatry, University of Cambridge, Cambridge, UK.
- 6Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. [email protected].
- 7UK Dementia Research Institute, University of Cambridge, Cambridge, UK. [email protected].
- 8Cambridge University Hospitals NHS Trust, Cambridge, UK. [email protected].
Abstract
Brain inflammation is a key feature of frontotemporal dementia (FTD). Positron emission tomography (PET) of the 18 kDa translocator protein (TSPO) is widely used as an in vivo proxy for neuroinflammation, but whether the elevated signal reflects microglial, astrocytic or vascular pathology remains controversial, and this has not previously been resolved in FTD using matched ante mortem imaging and post-mortem tissue. We paired ante mortem [¹¹C]PK11195 TSPO-PET with quantitative post-mortem neuropathology in 10 individuals with FTD (5 FTLD-tau, 5 FTLD-TDP) and 5 age- and sex-matched controls, combining CD68 immunohistochemistry across 17 brain regions, multiplex immunofluorescence pairing TSPO with microglial/macrophagic (IBA1, CD68), astrocytic (GFAP) and endothelial (CD31) markers in three frontotemporal cortical regions, and three-dimensional single-cell reconstruction of individual microglia. CD68 area fraction was elevated in FTD relative to controls, predominantly in white matter, and was positively associated with regional TSPO-PET-binding potential across the cohort (β = 8.66, P < 0.001), with comparable slopes in FTLD-tau and FTLD-TDP. Total tissue TSPO-area fraction was likewise increased in FTD and tracked regional PET binding in two independently processed slide sets. Of the four cell-type markers, only the CD68-TSPO co-localised fraction was positively associated with the PET signal (β = +0.0041, P = 0.015, PFDR = 0.062), with null or negative associations for IBA1, GFAP and CD31. At single-cell resolution, IBA1+ microglia that were also CD68+ carried more absolute TSPO and were larger than CD68- microglia, without an increase in the TSPO fraction of cell volume. The elevated TSPO-PET signal in FTD, therefore, likely reflects an increased burden of CD68+ phagocytic microglia rather than TSPO expression in other cell types, supporting TSPO-PET as a microglial-burden biomarker across both FTLD-tau and FTLD-TDP.
Related
- Somatic instability of the C9orf72 repeat expansion in blood differs between patients with amyotrophic lateral sclerosis or frontotemporal dementia.
- Phase 3 randomized trial of latozinemab in frontotemporal dementia due to GRN mutations
- Preclinical and clinical investigation of VES001, an oral small molecule sortilin receptor inhibitor for the treatment of frontotemporal dementia: a first-in-human randomized placebo-controlled phase 1 trial.
- Shared and Divergent Multisensory Emotion Perception Deficits across Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia: A Systematic Review and Hierarchical Bayesian Meta-Analysis
- Genetic Spectrum, Family History and Diagnostic Yield of Targeted Genetic Testing in Early-Onset Alzheimer's Disease and Frontotemporal Dementia: A Serbian Memory Clinic.
BibTeX
@article{vontobel2026tspopet,
title = {{TSPO-PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia.}},
author = {Davi S Vontobel and Kei Onn Lai and Mehtap Bacioglu and George Nolan and Daniel C Maddison and Amelie Adamski and Julia Goddard and Noah L Shapiro and Harry Crook and Tim Fryer and Young Hong and Sasvi Wijesinghe and Franklin Aigbirhio and Edward Avezov and Kieren S J Allinson and Annelies Quaegebeur and John T O'Brien and James B Rowe and Maria Grazia Spillantini and Maura Malpetti},
journal = {Acta neuropathologica},
year = {2026},
month = oct,
doi = {10.1007/s00401-026-03103-5},
url = {https://europepmc.org/article/MED/42911238},
note = {CC BY},
}
RIS
TY - JOUR
TI - TSPO-PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia.
AU - Davi S Vontobel
AU - Kei Onn Lai
AU - Mehtap Bacioglu
AU - George Nolan
AU - Daniel C Maddison
AU - Amelie Adamski
AU - Julia Goddard
AU - Noah L Shapiro
AU - Harry Crook
AU - Tim Fryer
AU - Young Hong
AU - Sasvi Wijesinghe
AU - Franklin Aigbirhio
AU - Edward Avezov
AU - Kieren S J Allinson
AU - Annelies Quaegebeur
AU - John T O'Brien
AU - James B Rowe
AU - Maria Grazia Spillantini
AU - Maura Malpetti
PY - 2026
DA - 2026/10/22
JO - Acta neuropathologica
DO - 10.1007/s00401-026-03103-5
UR - https://europepmc.org/article/MED/42911238
AB - Brain inflammation is a key feature of frontotemporal dementia (FTD). Positron emission tomography (PET) of the 18 kDa translocator protein (TSPO) is widely used as an in vivo proxy for neuroinflammation, but whether the elevated signal reflects microglial, astrocytic or vascular pathology remains controversial, and this has not previously been resolved in FTD using matched ante mortem imaging and post-mortem tissue. We paired ante mortem [¹¹C]PK11195 TSPO-PET with quantitative post-mortem neuropathology in 10 individuals with FTD (5 FTLD-tau, 5 FTLD-TDP) and 5 age- and sex-matched controls, combining CD68 immunohistochemistry across 17 brain regions, multiplex immunofluorescence pairing TSPO with microglial/macrophagic (IBA1, CD68), astrocytic (GFAP) and endothelial (CD31) markers in three frontotemporal cortical regions, and three-dimensional single-cell reconstruction of individual microglia. CD68 area fraction was elevated in FTD relative to controls, predominantly in white matter, and was positively associated with regional TSPO-PET-binding potential across the cohort (β = 8.66, P < 0.001), with comparable slopes in FTLD-tau and FTLD-TDP. Total tissue TSPO-area fraction was likewise increased in FTD and tracked regional PET binding in two independently processed slide sets. Of the four cell-type markers, only the CD68-TSPO co-localised fraction was positively associated with the PET signal (β = +0.0041, P = 0.015, PFDR = 0.062), with null or negative associations for IBA1, GFAP and CD31. At single-cell resolution, IBA1+ microglia that were also CD68+ carried more absolute TSPO and were larger than CD68- microglia, without an increase in the TSPO fraction of cell volume. The elevated TSPO-PET signal in FTD, therefore, likely reflects an increased burden of CD68+ phagocytic microglia rather than TSPO expression in other cell types, supporting TSPO-PET as a microglial-burden biomarker across both FTLD-tau and FTLD-TDP.
SN - 0001-6322
SN - 1432-0533
ER -